Global Bio-protein Drug Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Bio-protein Drug
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Bio-protein Drug Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Monoclonal Antibodies
        1.3.3 Therapeutic Proteins
        1.3.4 Vaccines
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Bio-protein Drug Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Pharma and Biotech Companies
        1.4.3 CROs
        1.4.4 Academics
    1.5 Global Bio-protein Drug Market Size & Forecast
        1.5.1 Global Bio-protein Drug Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Bio-protein Drug Sales Quantity (2018-2029)
        1.5.3 Global Bio-protein Drug Average Price (2018-2029) 
2 Manufacturers Profiles
    2.1 Abbott Laboratories
        2.1.1 Abbott Laboratories Details
        2.1.2 Abbott Laboratories Major Business
        2.1.3 Abbott Laboratories Bio-protein Drug Product and Services
        2.1.4 Abbott Laboratories Bio-protein Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Abbott Laboratories Recent Developments/Updates
    2.2 Bayer AG
        2.2.1 Bayer AG Details
        2.2.2 Bayer AG Major Business
        2.2.3 Bayer AG Bio-protein Drug Product and Services
        2.2.4 Bayer AG Bio-protein Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Bayer AG Recent Developments/Updates
    2.3 Eli Lilly and Company
        2.3.1 Eli Lilly and Company Details
        2.3.2 Eli Lilly and Company Major Business
        2.3.3 Eli Lilly and Company Bio-protein Drug Product and Services
        2.3.4 Eli Lilly and Company Bio-protein Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Eli Lilly and Company Recent Developments/Updates
    2.4 Amgen Inc.
        2.4.1 Amgen Inc. Details
        2.4.2 Amgen Inc. Major Business
        2.4.3 Amgen Inc. Bio-protein Drug Product and Services
        2.4.4 Amgen Inc. Bio-protein Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Amgen Inc. Recent Developments/Updates
    2.5 Biocon Ltd.
        2.5.1 Biocon Ltd. Details
        2.5.2 Biocon Ltd. Major Business
        2.5.3 Biocon Ltd. Bio-protein Drug Product and Services
        2.5.4 Biocon Ltd. Bio-protein Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Biocon Ltd. Recent Developments/Updates
    2.6 Dr. Reddy’s Laboratories
        2.6.1 Dr. Reddy’s Laboratories Details
        2.6.2 Dr. Reddy’s Laboratories Major Business
        2.6.3 Dr. Reddy’s Laboratories Bio-protein Drug Product and Services
        2.6.4 Dr. Reddy’s Laboratories Bio-protein Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Dr. Reddy’s Laboratories Recent Developments/Updates
    2.7 Roche
        2.7.1 Roche Details
        2.7.2 Roche Major Business
        2.7.3 Roche Bio-protein Drug Product and Services
        2.7.4 Roche Bio-protein Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Roche Recent Developments/Updates
    2.8 Fresenius kabi
        2.8.1 Fresenius kabi Details
        2.8.2 Fresenius kabi Major Business
        2.8.3 Fresenius kabi Bio-protein Drug Product and Services
        2.8.4 Fresenius kabi Bio-protein Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Fresenius kabi Recent Developments/Updates
    2.9 GlaxoSmithKline
        2.9.1 GlaxoSmithKline Details
        2.9.2 GlaxoSmithKline Major Business
        2.9.3 GlaxoSmithKline Bio-protein Drug Product and Services
        2.9.4 GlaxoSmithKline Bio-protein Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 GlaxoSmithKline Recent Developments/Updates
    2.10 Johnson & Johnson
        2.10.1 Johnson & Johnson Details
        2.10.2 Johnson & Johnson Major Business
        2.10.3 Johnson & Johnson Bio-protein Drug Product and Services
        2.10.4 Johnson & Johnson Bio-protein Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Johnson & Johnson Recent Developments/Updates
    2.11 Merck
        2.11.1 Merck Details
        2.11.2 Merck Major Business
        2.11.3 Merck Bio-protein Drug Product and Services
        2.11.4 Merck Bio-protein Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Merck Recent Developments/Updates
    2.12 Novartis AG
        2.12.1 Novartis AG Details
        2.12.2 Novartis AG Major Business
        2.12.3 Novartis AG Bio-protein Drug Product and Services
        2.12.4 Novartis AG Bio-protein Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Novartis AG Recent Developments/Updates
    2.13 Panacea Biotec
        2.13.1 Panacea Biotec Details
        2.13.2 Panacea Biotec Major Business
        2.13.3 Panacea Biotec Bio-protein Drug Product and Services
        2.13.4 Panacea Biotec Bio-protein Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 Panacea Biotec Recent Developments/Updates
    2.14 ProBioGen AG
        2.14.1 ProBioGen AG Details
        2.14.2 ProBioGen AG Major Business
        2.14.3 ProBioGen AG Bio-protein Drug Product and Services
        2.14.4 ProBioGen AG Bio-protein Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.14.5 ProBioGen AG Recent Developments/Updates
    2.15 Sanofi
        2.15.1 Sanofi Details
        2.15.2 Sanofi Major Business
        2.15.3 Sanofi Bio-protein Drug Product and Services
        2.15.4 Sanofi Bio-protein Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.15.5 Sanofi Recent Developments/Updates
    2.16 Reliance Life Science Pvt. Ltd.
        2.16.1 Reliance Life Science Pvt. Ltd. Details
        2.16.2 Reliance Life Science Pvt. Ltd. Major Business
        2.16.3 Reliance Life Science Pvt. Ltd. Bio-protein Drug Product and Services
        2.16.4 Reliance Life Science Pvt. Ltd. Bio-protein Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.16.5 Reliance Life Science Pvt. Ltd. Recent Developments/Updates
3 Competitive Environment: Bio-protein Drug by Manufacturer
    3.1 Global Bio-protein Drug Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Bio-protein Drug Revenue by Manufacturer (2018-2023)
    3.3 Global Bio-protein Drug Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Bio-protein Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Bio-protein Drug Manufacturer Market Share in 2022
        3.4.2 Top 6 Bio-protein Drug Manufacturer Market Share in 2022
    3.5 Bio-protein Drug Market: Overall Company Footprint Analysis
        3.5.1 Bio-protein Drug Market: Region Footprint
        3.5.2 Bio-protein Drug Market: Company Product Type Footprint
        3.5.3 Bio-protein Drug Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
    4.1 Global Bio-protein Drug Market Size by Region
        4.1.1 Global Bio-protein Drug Sales Quantity by Region (2018-2029)
        4.1.2 Global Bio-protein Drug Consumption Value by Region (2018-2029)
        4.1.3 Global Bio-protein Drug Average Price by Region (2018-2029)
    4.2 North America Bio-protein Drug Consumption Value (2018-2029)
    4.3 Europe Bio-protein Drug Consumption Value (2018-2029)
    4.4 Asia-Pacific Bio-protein Drug Consumption Value (2018-2029)
    4.5 South America Bio-protein Drug Consumption Value (2018-2029)
    4.6 Middle East and Africa Bio-protein Drug Consumption Value (2018-2029)
5 Market Segment by Type
    5.1 Global Bio-protein Drug Sales Quantity by Type (2018-2029)
    5.2 Global Bio-protein Drug Consumption Value by Type (2018-2029)
    5.3 Global Bio-protein Drug Average Price by Type (2018-2029)
6 Market Segment by Application
    6.1 Global Bio-protein Drug Sales Quantity by Application (2018-2029)
    6.2 Global Bio-protein Drug Consumption Value by Application (2018-2029)
    6.3 Global Bio-protein Drug Average Price by Application (2018-2029)
7 North America
    7.1 North America Bio-protein Drug Sales Quantity by Type (2018-2029)
    7.2 North America Bio-protein Drug Sales Quantity by Application (2018-2029)
    7.3 North America Bio-protein Drug Market Size by Country
        7.3.1 North America Bio-protein Drug Sales Quantity by Country (2018-2029)
        7.3.2 North America Bio-protein Drug Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
    8.1 Europe Bio-protein Drug Sales Quantity by Type (2018-2029)
    8.2 Europe Bio-protein Drug Sales Quantity by Application (2018-2029)
    8.3 Europe Bio-protein Drug Market Size by Country
        8.3.1 Europe Bio-protein Drug Sales Quantity by Country (2018-2029)
        8.3.2 Europe Bio-protein Drug Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
    9.1 Asia-Pacific Bio-protein Drug Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Bio-protein Drug Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Bio-protein Drug Market Size by Region
        9.3.1 Asia-Pacific Bio-protein Drug Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Bio-protein Drug Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
    10.1 South America Bio-protein Drug Sales Quantity by Type (2018-2029)
    10.2 South America Bio-protein Drug Sales Quantity by Application (2018-2029)
    10.3 South America Bio-protein Drug Market Size by Country
        10.3.1 South America Bio-protein Drug Sales Quantity by Country (2018-2029)
        10.3.2 South America Bio-protein Drug Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
    11.1 Middle East & Africa Bio-protein Drug Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Bio-protein Drug Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Bio-protein Drug Market Size by Country
        11.3.1 Middle East & Africa Bio-protein Drug Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Bio-protein Drug Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
    12.1 Bio-protein Drug Market Drivers
    12.2 Bio-protein Drug Market Restraints
    12.3 Bio-protein Drug Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
    13.1 Raw Material of Bio-protein Drug and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Bio-protein Drug
    13.3 Bio-protein Drug Production Process
    13.4 Bio-protein Drug Industrial Chain
14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Bio-protein Drug Typical Distributors
    14.3 Bio-protein Drug Typical Customers
15 Research Findings and Conclusion
16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer